Qiagen Ready To Rival Abbott With Rapid, Portable Antigen COVID-19 Test
The diagnostics company said the test is scheduled for US launch in Q4 2020.
You may also be interested in...
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
Qiagen's shareholders said Thermo Fisher's final offer price for the diagnostics company was too low.
Hedge fund Davidson Kempner advised Qiagen to ask for a higher acquisition price from Thermo Fisher Sciences as COVID-19 has increased demand for diagnostic products.